Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A14952 | 29158770 | Nutr Metab (Lond) | Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver? | 2017 | Details |
| A14953 | 29158183 | Biochim Biophys Acta Mol Basis Dis | Serine prevented high-fat diet-induced oxidative stress by activating AMPK and epigenetically modulating the expression of glutathione synthesis-related genes. | 2017 | Details |
| A14954 | 29158157 | Clin Gastroenterol Hepatol | Nonalcoholic Fatty Liver Disease Associates With Increased Overall Mortality and Death From Cancer, Cardiovascular Disease, and Liver Disease in Women but Not Men. | 2017 | Details |
| A14955 | 29158088 | Biochem Biophys Res Commun | Interplay of adipocyte and hepatocyte: Leptin upregulates hepcidin. | 2017 | Details |
| A14956 | 29158052 | Life Sci | Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice. | 2017 | Details |
| A14957 | 29156529 | Biomed Pharmacother | Alpinetin improved high fat diet-induced non-alcoholic fatty liver disease (NAFLD) through improving oxidative stress, inflammatory response and lipid metabolism. | 2017 | Details |
| A14958 | 29156528 | Biomed Pharmacother | Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant. | 2017 | Details |
| A14959 | 29155718 | J Vis Exp | The Murine Choline-Deficient, Ethionine-Supplemented (CDE) Diet Model of Chronic Liver Injury. | 2017 | Details |
| A14960 | 29155143 | Eur J Pharmacol | Obeticholic acid raises LDL-cholesterol and reduces HDL-cholesterol in the Diet-Induced NASH (DIN) hamster model. | 2017 | Details |
| A14961 | 29154966 | J Hepatol | Determinants of fibrosis progression and regression in NASH. | 2017 | Details |
| A14962 | 29154965 | J Hepatol | Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers. | 2017 | Details |
| A14963 | 29154964 | J Hepatol | Lipotoxicity and the gut-liver axis in NASH pathogenesis. | 2017 | Details |
| A14964 | 29154469 | Pathol Int | Novel non-alcoholic steatohepatitis model with histopathological and insulin-resistant features. | 2017 | Details |
| A14965 | 29152605 | Hepatol Commun | Hepatic Natural Killer T-cell and CD8+ T-cell Signatures in Mice with Nonalcoholic Steatohepatitis. | 2017 | Details |
| A14968 | 29151501 | Intern Med | The Efficacy of Corticosteroid Therapy in a Patient with Non-alcoholic Steatohepatitis Overlapping Autoimmune Hepatitis. | 2017 | Details |
| A14969 | 29151428 | J Clin Sleep Med | Continuous Positive Airway Pressure in Patients With Obstructive Sleep Apnea and Non-Alcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. | 2018 | Details |
| A14970 | 29151327 | Clin Mol Hepatol | Serum matrix metalloproteinase-1 level represents disease activity as opposed to fibrosis in patients with histologically proven nonalcoholic steatohepatitis. | 2017 | Details |
| A14971 | 29150932 | J Cell Physiol | High fat diet-induced oxidative stress blocks hepatocyte nuclear factor 4α and leads to hepatic steatosis in mice. | 2018 | Details |
| A14972 | 29150621 | Sci Rep | PNPLA3 variant and portal/periportal histological pattern in patients with biopsy-proven non-alcoholic fatty liver disease: a possible role for oxidative stress. | 2017 | Details |
| A14973 | 29150490 | Gut | Gut roundtable meeting paper: selected recent advances in hepatocellular carcinoma. | 2017 | Details |
| A14974 | 29150142 | J Hepatol | Association between non-alcoholic fatty liver disease and cancer incidence rate. | 2017 | Details |
| A14975 | 29149647 | J Nutr Biochem | Dietary fish oil differentially ameliorates high-fructose diet-induced hepatic steatosis and hyperlipidemia in mice depending on time of feeding. | 2017 | Details |
| A14976 | 29148806 | J Med Chem | Discovery of Tropifexor (LJN452), a Highly Potent Non-bile Acid FXR Agonist for the Treatment of Cholestatic Liver Diseases and Nonalcoholic Steatohepatitis (NASH). | 2017 | Details |
| A14977 | 29148175 | J Dig Dis | Treatment efficacy of a probiotic preparation for non-alcoholic steatohepatitis: A pilot trial. | 2017 | Details |
| A14978 | 29146119 | Diabetes Res Clin Pract | An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis. | 2017 | Details |
| A14979 | 29145775 | Trop Doct | Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). | 2017 | Details |
| A14980 | 29145614 | Toxicol Sci | Asking the Right Questions With Animal Models: Methionine- and Choline-Deficient Model in Predicting Adverse Drug Reactions in Human NASH. | 2018 | Details |
| A14981 | 29144460 | Nature | Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. | 2017 | Details |
| A14982 | 29144438 | Antioxidants (Basel) | Bioactive Components in Moringa Oleifera Leaves Protect against Chronic Disease. | 2017 | Details |
| A14983 | 29142082 | Neurology | Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy. | 2017 | Details |
| A14984 | 29141573 | Endocr Metab Immune Disord Drug Targets | Liver Protective Effects of Extra Virgin Olive Oil: Interaction between Its Chemical Composition and the Cell-signaling Pathways Involved in Protection. | 2018 | Details |
| A14985 | 29139555 | Br J Pharmacol | Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. | 2018 | Details |
| A14986 | 29138984 | Curr Hypertens Rep | 11β-Hydroxysteroid Dehydrogenases and Hypertension in the Metabolic Syndrome. | 2017 | Details |
| A14987 | 29138227 | Am J Physiol Endocrinol Metab | The hepatokines fetuin-A and fetuin-B are upregulated in the state of hepatic steatosis and may differently impact on glucose homeostasis in humans. | 2017 | Details |
| A14988 | 29137912 | Metabolism | Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis. | 2017 | Details |
| A14989 | 29137289 | Oncotarget | Lingguizhugan decoction improves non-alcoholic fatty liver disease by altering insulin resistance and lipid metabolism related genes: a whole trancriptome study by RNA-Seq. | 2017 | Details |
| A14990 | 29136950 | Biomed Pharmacother | A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells. | 2017 | Details |
| A14991 | 29135945 | Nutrients | Nutritional Profile and Dietary Patterns of Lebanese Non-Alcoholic Fatty Liver Disease Patients: A Case-Control Study. | 2017 | Details |
| A14992 | 29133512 | Diabetes | Exosomes From Adipose-Derived Stem Cells Attenuate Adipose Inflammation and Obesity Through Polarizing M2 Macrophages and Beiging in White Adipose Tissue. | 2017 | Details |
| A14993 | 29133343 | Diabetes Care | Clinical and Histologic Characterization of Nonalcoholic Steatohepatitis in African American Patients. | 2017 | Details |
| A14994 | 29132522 | Prim Care | Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14995 | 29132235 | SLAS Discov | A Cell-Based Assay to Investigate Hypolipidemic Effects of Nonalcoholic Fatty Liver Disease Therapeutics. | 2017 | Details |
| A14996 | 29131401 | J Gastroenterol Hepatol | Non-alcoholic fatty liver disease and the development of reflux esophagitis: A cohort study. | 2018 | Details |
| A14997 | 29130539 | NMR Biomed | Sources of systematic error in proton density fat fraction (PDFF) quantification in the liver evaluated from magnitude images with different numbers of echoes. | 2017 | Details |
| A14998 | 29130075 | Hepatol Commun | Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A14999 | 29129819 | Metabolism | Nicotinic acetylcholine receptor α7 subunit improves energy homeostasis and inhibits inflammation in nonalcoholic fatty liver disease. | 2017 | Details |
| A15000 | 29129237 | Nutrition | Iron-induced pro-oxidant and pro-lipogenic responses in relation to impaired synthesis and accretion of long-chain polyunsaturated fatty acids in rat hepatic and extrahepatic tissues. | 2017 | Details |
| A15001 | 29128938 | J Med Ultrason (2001) | Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15002 | 29128391 | J Hepatol | Preclinical models of non-alcoholic fatty liver disease. | 2017 | Details |
| A15003 | 29128353 | Biochem Biophys Res Commun | Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis. | 2017 | Details |
| A15004 | 29128158 | Trends Endocrinol Metab | Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism. | 2017 | Details |
| A15006 | 29128063 | Clin Liver Dis | Radiologic Imaging in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15007 | 29128062 | Clin Liver Dis | Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Noninvasive Biomarkers and Transient Elastography. | 2018 | Details |
| A15008 | 29128061 | Clin Liver Dis | The Genetics of Pediatric Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15009 | 29128060 | Clin Liver Dis | Risk Factors for the Development of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis, Including Genetics. | 2017 | Details |
| A15010 | 29128059 | Clin Liver Dis | Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15011 | 29128058 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis in Liver Transplantation. | 2017 | Details |
| A15012 | 29128057 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma. | 2018 | Details |
| A15013 | 29128056 | Clin Liver Dis | Emerging Treatments for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15014 | 29128055 | Clin Liver Dis | Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15015 | 29128054 | Clin Liver Dis | The Role of Nonalcoholic Fatty Liver Disease on Cardiovascular Manifestations and Outcomes. | 2017 | Details |
| A15016 | 29128053 | Clin Liver Dis | Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. | 2017 | Details |
| A15017 | 29128052 | Clin Liver Dis | The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A15018 | 29128051 | Clin Liver Dis | The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View. | 2018 | Details |
| A15019 | 29128050 | Clin Liver Dis | The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom. | 2018 | Details |
| A15020 | 29128049 | Clin Liver Dis | Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15021 | 29127188 | FASEB J | Epigenetically mediated inhibition of S-adenosylhomocysteine hydrolase and the associated dysregulation of 1-carbon metabolism in nonalcoholic steatohepatitis and hepatocellular carcinoma. | 2018 | Details |
| A15022 | 29126901 | Biochim Biophys Acta Mol Cell Biol Lipids | Omega-3 polyunsaturated fatty acids protect human hepatoma cells from developing steatosis through FFA4 (GPR120). | 2017 | Details |
| A15023 | 29126873 | Mol Metab | Dual role of protein tyrosine phosphatase 1B in the progression and reversion of non-alcoholic steatohepatitis. | 2017 | Details |
| A15024 | 29126863 | Surg Obes Relat Dis | Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients. | 2017 | Details |
| A15025 | 29126168 | Endocrinology | Endocrine Disruptors and Developmental Origins of Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A15026 | 29125712 | Liver Transpl | Lipid metabolism and functional assessment of discarded human livers with steatosis undergoing 24 hours of normothermic machine perfusion. | 2018 | Details |
| A15027 | 29125642 | J Food Sci | Genistein Ameliorates Fat Accumulation Through AMPK Activation in Fatty Acid-Induced BRL Cells. | 2017 | Details |
| A15029 | 29124703 | Adv Exp Med Biol | Vitamin D, Cardiovascular Disease and Risk Factors. | 2017 | Details |
| A15031 | 29122967 | Clin Sci (Lond) | Hepatic accumulation of S-adenosylmethionine in hamsters with non-alcoholic fatty liver disease associated with metabolic syndrome under selenium and vitamin E deficiency. | 2019 | Details |
| A15032 | 29122851 | Gut | Guidelines on the management of abnormal liver blood tests. | 2017 | Details |
| A15033 | 29122831 | Arch Dis Child Educ Pract Ed | Fifteen-minute consultation: liver disease in children. | 2017 | Details |
| A15034 | 29122695 | J Hepatol | Should we undertake surveillance for HCC in patients with NAFLD? | 2017 | Details |
| A15035 | 29122694 | J Hepatol | Pharmacotherapy for NASH: Current and emerging. | 2017 | Details |
| A15036 | 29122679 | Mol Aspects Med | Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis. | 2017 | Details |
| A15037 | 29122442 | Nutr Metab Cardiovasc Dis | Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease. | 2017 | Details |
| A15038 | 29122391 | J Hepatol | Genetics and epigenetics of NAFLD and NASH: Clinical impact. | 2017 | Details |
| A15039 | 29122390 | J Hepatol | Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? | 2017 | Details |
| A15040 | 29122389 | J Hepatol | The nutritional geometry of liver disease including non-alcoholic fatty liver disease. | 2017 | Details |
| A15041 | 29121861 | BMC Genomics | Transcriptomics, metabolomics and histology indicate that high-carbohydrate diet negatively affects the liver health of blunt snout bream (Megalobrama amblycephala). | 2017 | Details |
| A15042 | 29121675 | PLoS One | Astaxanthin prevents ischemia-reperfusion injury of the steatotic liver in mice. | 2017 | Details |
| A15043 | 29120742 | Cell Host Microbe | The Human Microbiome and Obesity: Moving beyond Associations. | 2017 | Details |
| A15044 | 29119725 | Obes Rev | Systematic review and meta-analysis: non-invasive detection of non-alcoholic fatty liver disease related fibrosis in the obese. | 2017 | Details |
| A15045 | 29119610 | Hepatology | Association of vitamin E intake at early childhood with alanine aminotransferase levels at mid-childhood. | 2018 | Details |
| A15046 | 29119374 | J Nucl Cardiol | Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2017. Part 1 of 2: Positron emission tomography, computed tomography, and magnetic resonance. | 2017 | Details |
| A15047 | 29119336 | Obes Surg | Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study. | 2018 | Details |
| A15048 | 29118995 | Open Heart | Added fructose as a principal driver of non-alcoholic fatty liver disease: a public health crisis. | 2017 | Details |
| A15049 | 29118867 | Gastroenterology Res | Non-Alcoholic Fatty Liver Disease in Africa and Middle East: An Attempt to Predict the Present and Future Implications on the Healthcare System. | 2017 | Details |
| A15050 | 29118811 | Int J Endocrinol | Obese Children with Metabolic Syndrome Have 3 Times Higher Risk to Have Nonalcoholic Fatty Liver Disease Compared with Those without Metabolic Syndrome. | 2017 | Details |
| A15051 | 29118561 | Ann Gastroenterol | Pilot study of the prevalence of binge eating disorder in non-alcoholic fatty liver disease patients. | 2017 | Details |
| A15052 | 29118014 | Am J Physiol Endocrinol Metab | Exercise training reduces intrahepatic lipid content in people with and people without nonalcoholic fatty liver. | 2017 | Details |
| A15053 | 29117861 | BMC Gastroenterol | Correction to: "Non alcoholic fatty liver disease and eNOS dysfunction in humans". | 2017 | Details |
| A15054 | 29117763 | Toxicol Mech Methods | Pilose antler peptide attenuates high-fat-diet-induced liver injury. | 2017 | Details |
| A15055 | 29093809 | F1000Res | Gender differences in the prevalence of nonalcoholic fatty liver disease in the Northeast of Thailand: A population-based cross-sectional study. | 2017 | Details |
| A15056 | 29117472 | Liver Int | Text messaging approach improves weight loss in patients with nonalcoholic fatty liver disease: A randomized study. | 2017 | Details |